AU1152200A - Pharmaceutical composition, containing fragments of an antigenic protein encoding dna endowed with anti-tumor effect - Google Patents

Pharmaceutical composition, containing fragments of an antigenic protein encoding dna endowed with anti-tumor effect

Info

Publication number
AU1152200A
AU1152200A AU11522/00A AU1152200A AU1152200A AU 1152200 A AU1152200 A AU 1152200A AU 11522/00 A AU11522/00 A AU 11522/00A AU 1152200 A AU1152200 A AU 1152200A AU 1152200 A AU1152200 A AU 1152200A
Authority
AU
Australia
Prior art keywords
endowed
pharmaceutical composition
encoding dna
tumor effect
antigenic protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU11522/00A
Other languages
English (en)
Inventor
Rita De Santis
Anna Maria Di Massimo
Dino Parente
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Menarini Ricerche SpA
Original Assignee
Menarini Ricerche SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini Ricerche SpA filed Critical Menarini Ricerche SpA
Publication of AU1152200A publication Critical patent/AU1152200A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4727—Mucins, e.g. human intestinal mucin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001136—Cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU11522/00A 1998-10-30 1999-10-18 Pharmaceutical composition, containing fragments of an antigenic protein encoding dna endowed with anti-tumor effect Abandoned AU1152200A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI98A2330 1998-10-30
IT1998MI002330A IT1303683B1 (it) 1998-10-30 1998-10-30 Composizione farmaceutiche ad azione antitumorale contenente dnacodificante per frammenti di una proteina antigenica.
PCT/EP1999/007874 WO2000025827A2 (en) 1998-10-30 1999-10-18 Dna molecules encoding muc-1 and use thereof in tumor vaccination

Publications (1)

Publication Number Publication Date
AU1152200A true AU1152200A (en) 2000-05-22

Family

ID=11380969

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11522/00A Abandoned AU1152200A (en) 1998-10-30 1999-10-18 Pharmaceutical composition, containing fragments of an antigenic protein encoding dna endowed with anti-tumor effect

Country Status (19)

Country Link
EP (1) EP1124956A2 (de)
JP (1) JP2002528519A (de)
CN (1) CN1324406A (de)
AR (1) AR020927A1 (de)
AU (1) AU1152200A (de)
BG (1) BG105458A (de)
BR (1) BR9914892A (de)
CA (1) CA2348745A1 (de)
CO (1) CO5231134A1 (de)
CZ (1) CZ20011521A3 (de)
EA (1) EA200100395A1 (de)
HU (1) HUP0103784A2 (de)
IT (1) IT1303683B1 (de)
MX (1) MXPA01004186A (de)
PE (1) PE20001287A1 (de)
PL (1) PL348156A1 (de)
SK (1) SK5712001A3 (de)
TR (1) TR200101141T2 (de)
WO (1) WO2000025827A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548643B1 (en) 1994-11-16 2003-04-15 Austin Research Institute Antigen carbohydrate compounds and their use in immunotherapy
JP2003533181A (ja) * 2000-02-01 2003-11-11 ジ・オースティン・リサーチ・インスティテュート ムチン−１誘導抗原および免疫療法におけるその使用
KR20030068536A (ko) * 2000-09-11 2003-08-21 다나-파버 캔서 인스티튜트 Ｍｕｃ1 세포외 도메인 및 이로부터 유래된 암 치료조성물과 방법
EP1531842A4 (de) 2000-12-22 2007-03-07 Dana Farber Cancer Inst Inc Regulation des zellwachstums durch muc1
DK1622648T3 (da) * 2003-03-24 2010-09-06 Scripps Research Inst DNA-vacciner mod tumorvækst og fremgangsmåder til anvendelse deraf
US7696306B2 (en) 2003-07-11 2010-04-13 Board of Agents of the University of Nebraska Compositions and methods for preventing or treating cancer
WO2005042573A1 (en) * 2003-10-24 2005-05-12 Dana-Farber Cancer Institute, Inc. Modulation of the interaction of muc1 with muc1 ligands
US7972870B2 (en) 2007-02-02 2011-07-05 Dana-Farber Cancer Institute, Inc. Methods and compositions relating to the regulation of MUC1 by HSF1 and STAT3
WO2008097844A2 (en) 2007-02-02 2008-08-14 Dana -Farber Cancer Institute, Inc. Methods and compositions relating to the regulation of apoptosis by muc1 and bh3- containing proapoptotic proteins
CN106279435B (zh) * 2016-08-16 2019-06-07 新乡医学院 靶向VEGF与mucin1的抗肿瘤疫苗、编码基因、表达载体、表达工程菌及应用
CN114230655A (zh) * 2021-03-24 2022-03-25 深圳市新靶向生物科技有限公司 一种与食道癌驱动基因突变相关的抗原肽组合及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1262545B (it) * 1993-10-25 1996-07-02 Menarini Ricerche Sud S P A A Sistema di espressione per linee cellulari eucariotiche
EP1012276A2 (de) * 1997-02-24 2000-06-28 Therion Biologics Corporation Rekombinantes poxvirus zur immunisierung gegen muc1 tumor-assoziiertes antigen

Also Published As

Publication number Publication date
EP1124956A2 (de) 2001-08-22
BG105458A (en) 2002-06-28
PE20001287A1 (es) 2000-12-07
IT1303683B1 (it) 2001-02-23
WO2000025827A3 (en) 2000-08-10
EA200100395A1 (ru) 2001-10-22
CA2348745A1 (en) 2000-05-11
ITMI982330A1 (it) 2000-04-30
WO2000025827A2 (en) 2000-05-11
TR200101141T2 (tr) 2001-09-21
PL348156A1 (en) 2002-05-06
CZ20011521A3 (cs) 2001-10-17
HUP0103784A2 (hu) 2002-02-28
BR9914892A (pt) 2001-07-17
AR020927A1 (es) 2002-06-05
JP2002528519A (ja) 2002-09-03
ITMI982330A0 (it) 1998-10-30
MXPA01004186A (es) 2002-06-04
CN1324406A (zh) 2001-11-28
SK5712001A3 (en) 2002-04-04
CO5231134A1 (es) 2002-12-27

Similar Documents

Publication Publication Date Title
AU1152200A (en) Pharmaceutical composition, containing fragments of an antigenic protein encoding dna endowed with anti-tumor effect
AU7072896A (en) Dna encoding medicinal proteins
AU5245900A (en) Novel protein and dna thereof
AU3670395A (en) Hippocampus-associated proteins, dna sequences coding therefor and uses thereof
AU4990999A (en) Survivin, and peptides thereof, as an anti-cancer vaccine
AU1183200A (en) Novel gene encoding brain-specific membrane protein
AU2003247537A1 (en) Chd5 encoding nucleic acids, polypeptides, antibodies and methods of use thereof
AU2001265213A1 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
AU7846000A (en) Novel human lipase proteins, nucleic acids encoding them, and uses of both of these
AU2002307848A1 (en) Ifn-thy fusion protein,dna coding therefore,its preparation and application
AU2001272910A1 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
AU2225401A (en) Novel protein and dna thereof
AU6181500A (en) Gene encoding novel tsp1-like protein
AU2001271276A1 (en) Isolated human aminotransferase proteins, nucleic acid molecules encoding human aminotransferase proteins, and uses thereof
AU2002337248A1 (en) Nucleic acids coding for novel fbox proteins, their diagnostic and therapeutic uses
AU1690200A (en) Novel protein and dna thereof
AU5447999A (en) Novel protein and dna thereof
AU2002250273A1 (en) Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
AU2002306883A1 (en) Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
AU5300999A (en) Novel protein, gene encoding the same and utilization thereof
AU1183100A (en) Novel ubiquitin-like protein
AU2001292769A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof
AU2001288218A1 (en) Isolated human ion channel proteins, nucleic acid molecules encoding them, and uses thereof
AU2002250459A1 (en) Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
AU2002250348A1 (en) Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase